RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER
NCT03837223 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 271
Last updated 2019-02-12
Summary
Ovarian Hyperstimulation Syndrome (OHSS) is one of the most dangerous complications of Assisted Reproductive Technologies (ART) cycles. The use in clinical practice of the GnRH antagonist has made it possible to perform the trigger with GnRH analogues reducing the risk of OHSS. The trigger with analogue increases the Abortion Rate (AR) and reduces the Ongoing Pregnancy Rate (OPR), because the luteal phase in these cycles is particularly deficient. To reduce this occurrence several studies have focused on the importance of support of the luteal phase. The aims of study is to evaluate OPR and AR in patients at intermediate risk of OHSS (\<18 recovered oocytes) which performed GnRH trigger and rescue protocol.
Conditions
- GnRH Trigger and Rescue Protocol
Interventions
- DRUG
-
GnRH agonist
In High Responder patients (HR) (more than 18 follicles with diameter ≥ 12mm at ovulation induction), the trigger was obtained with triptorelin 0.2 mg sc. In this cohort if less of 18 oocytes were retrieved, patients were considered at intermediate risk of OHSS and fresh transfer was performed. An adequate support of the luteal phase was initiated: HCG 1500 IU / sc the day of the pick up + estradiol 4 mg + vaginal progesterone 400 mg daily (Rescue protocol).
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 38 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-01
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
More Related Trials
-
Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS
NCT02200952 ·Status: COMPLETED
-
Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS
NCT01477970 ·Status: COMPLETED
-
Ovarian Response in Oocyte Donors Triggered With GnRH Agonists
NCT05109403 ·Status: COMPLETED
-
A New Revolutionary 3-Injection- Protocol in Infertile Women
NCT03877185 ·Status: UNKNOWN
-
Preventive Application of GnRH Antagonist on Early OHSS
NCT03188471 ·Status: UNKNOWN ·Phase: PHASE4
-
Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation
NCT00633347 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality
NCT03139474 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration
NCT02330770 ·Status: RECRUITING ·Phase: PHASE4
-
GnRH Antagonist to Prepare Recipients for Embryo Transfer
NCT00460642 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program
NCT01922193 ·Status: COMPLETED ·Phase: PHASE3
-
Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a
NCT05143723 ·Status: UNKNOWN ·Phase: PHASE2
-
The Use of GnRH Agonist Trigger in the Prevention of OHSS
NCT00349258 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF Drugs
NCT00415792 ·Status: UNKNOWN ·Phase: PHASE4
-
GnRH Agonist as Luteal Support in FET Cycles
NCT02620124 ·Status: COMPLETED ·Phase: PHASE4
-
Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation
NCT01645241 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women
NCT01735422 ·Status: COMPLETED ·Phase: PHASE2
-
Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization
NCT02322398 ·Status: COMPLETED
-
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist
NCT01331733 ·Status: COMPLETED
-
Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation
NCT00417183 ·Status: UNKNOWN ·Phase: PHASE4
-
Gonadotropin Type in Ovarian Stimulation
NCT02437032 ·Status: COMPLETED ·Phase: PHASE4
-
Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F)
NCT01223079 ·Status: COMPLETED ·Phase: NA
-
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders
NCT04797338 ·Status: UNKNOWN ·Phase: PHASE4
-
The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol
NCT01636505 ·Status: UNKNOWN ·Phase: PHASE3
-
Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response
NCT02701452 ·Status: TERMINATED ·Phase: NA
-
Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression
NCT01565265 ·Status: COMPLETED ·Phase: NA